JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christian von Heymann
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christensen, M. C.
Right arrow Articles by von Heymann, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Christensen, M. C.
Right arrow Articles by von Heymann, C.
Related Collections
Right arrow Congestive Heart Failure
Right arrow Coronary disease
Right arrow Valve disease
Right arrowRelated Article

J Thorac Cardiovasc Surg 2009;138:687-693
© 2009 The American Association for Thoracic Surgery


Perioperative Management

Costs of excessive postoperative hemorrhage in cardiac surgery

Michael C. Christensen, MSc, MPA, DrPHa,*, Stephan Krapf, MDb, Angela Kempel, MScc, Christian von Heymann, MD, PhD, DEAAd

a Global Development, Novo Nordisk A/S, Bagsværd, Denmark
b Klinik für Herzchirurgie, Herzzentrum Augsburg, Augsburg, Germany
c Pharmametrics GmbH, Institute for Health Economics & Epidemiology, Freiburg, Germany
d Department of Anaesthesiology and Intensive Care Medicine, Charité-University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany

Received for publication March 17, 2008; revisions received September 12, 2008; accepted for publication February 2, 2009.

* Address for reprints: Michael C. Christensen, MSc, MPA, DrPH, Global Development, Novo Nordisk A/S, Krogshoejvej 55, 2880 Bagsvaerd, Denmark. (Email: mcrc{at}novonordisk.com).

Background: Excessive postoperative hemorrhage in cardiac surgery is a serious clinical complication placing substantial demands on hospital resources. This study quantifies the exact impact of postoperative hemorrhage on hospital costs in Germany.

Methods: We retrospectively analyzed data collected prospectively in the Quality Assurance Database at the Heart Center of the Klinikum Augsburg, Germany. All relevant perioperative data for resources consumption were analyzed and compared in patients with and without excessive postoperative hemorrhage in cardiac surgery. Multivariate regression analysis identified the incremental costs of postoperative hemorrhage while adjusting for potential confounding.

Results: A total of 1118 patients had cardiac surgery between January and December 2006. Six percent were identified with excessive postoperative hemorrhage. The risk of experiencing a postoperative complication (including death) (P < .0001), returning to operating room for reexploration (P < .0001), staying in intensive care unit for longer than 72 hours (P < .0001), receiving ventilation for longer than 24 hours (P < .0001), and receiving any kind of postoperative blood transfusion (P < .0001) was significantly higher in patients with excessive postoperative hemorrhage. Twenty-two percent of patients with excessive postoperative hemorrhage died compared with 6% of the patients without excessive postoperative hemorrhage (P < .0001). When adjusting for potential confounding factors, the incremental costs of excessive postoperative hemorrhage was \#8364;6251 (95% confidence interval, 4594–7909).

Conclusions: The average hospital costs related to excessive postoperative hemorrhage in cardiac surgery in Germany are substantial and associated with a significant risk of postoperative complications and death. Clinical interventions that can effectively prevent or address excessive postoperative hemorrhage in cardiac surgery are likely to have substantial cost-effectiveness potential.



Abbreviations and Acronyms AMI = acute myocardial infarction; CPB = cardiopulmonary bypass; ICU = intensive care unit; TISS-28 = Therapeutic Intervention Scoring System



Related Article

Knowing the cost of cardiac surgical complications: Does it really reduce them or improve quality?
Khaled Al-Ebrahim
J. Thorac. Cardiovasc. Surg. 2010 139: 1667. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Br J AnaesthHome page
U. Alstrom, L.- A. Levin, E. Stahle, R. Svedjeholm, and O. Friberg
Cost analysis of re-exploration for bleeding after coronary artery bypass graft surgery
Br. J. Anaesth., February 1, 2012; 108(2): 216 - 222.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
A. J. Chapman, A. L. Blount, A. T. Davis, and R. L. Hooker
Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery
Eur J Cardiothorac Surg, December 1, 2011; 40(6): 1314 - 1319.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. M. Sniecinski and J. H. Levy
Bleeding and management of coagulopathy
J. Thorac. Cardiovasc. Surg., September 1, 2011; 142(3): 662 - 667.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. A. Ferraris, D. L. Davenport, S. P. Saha, A. Bernard, P. C. Austin, and J. B. Zwischenberger
Intraoperative Transfusion of Small Amounts of Blood Heralds Worse Postoperative Outcome in Patients Having Noncardiac Thoracic Operations
Ann. Thorac. Surg., June 1, 2011; 91(6): 1674 - 1680.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Vivacqua, C. G. Koch, A. M. Yousuf, E. R. Nowicki, P. L. Houghtaling, E. H. Blackstone, and J. F. Sabik III
Morbidity of Bleeding After Cardiac Surgery: Is It Blood Transfusion, Reoperation for Bleeding, or Both?
Ann. Thorac. Surg., June 1, 2011; 91(6): 1780 - 1790.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. E. Uber, J. M. Toole, M. R. Stroud, J. S. Haney, J. Lazarchick, F. A. Crawford Jr., and J. S. Ikonomidis
Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: Clinical and economic outcomes
J. Thorac. Cardiovasc. Surg., June 1, 2011; 141(6): 1469 - 1477.e2.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. A. Hessel II and J. H. Levy
Guidelines for Perioperative Blood Transfusion and Conservation in Cardiac Surgery: Lessons and Challenges
Anesth. Analg., December 1, 2010; 111(6): 1555 - 1559.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. S. Likosky, D. C. FitzGerald, R. C. Groom, D. K. Jones, R. A. Baker, K. G. Shann, C. D. Mazer, B. D. Spiess, and S. C. Body
Special Article: Effect of the Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon Clinical Practices
Anesth. Analg., August 1, 2010; 111(2): 316 - 323.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.